The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Dr Khalaf Kheder Merza
    Born in May 1982
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Ismail, Mahdi Fadel
    Doctor born in September 1973
    Individual (8 offsprings)
    Officer
    2010-07-26 ~ dissolved
    OF - Director → CIF 0
    Dr Mahdi Fadel Ismail
    Born in September 1973
    Individual (8 offsprings)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

BRITT PHARM LTD

Previous names
FDAS BRITT LTD - 2013-04-29
BRITT-PHARM LTD - 2013-03-08
FDAS-BRITT LTD - 2012-08-31
BRIT-PHARM FDAS LTD - 2012-07-26
BRITT-PHARM LTD - 2012-05-28
Standard Industrial Classification
71200 - Technical Testing And Analysis
Brief company account
Debtors
13,080 GBP2023-07-31
55,778 GBP2022-07-31
Cash at bank and in hand
66 GBP2023-07-31
48 GBP2022-07-31
Current Assets
13,146 GBP2023-07-31
55,826 GBP2022-07-31
Net Current Assets/Liabilities
13,146 GBP2023-07-31
55,826 GBP2022-07-31
Total Assets Less Current Liabilities
13,146 GBP2023-07-31
55,826 GBP2022-07-31
Creditors
Amounts falling due after one year
-29,234 GBP2023-07-31
-82,348 GBP2022-07-31
Net Assets/Liabilities
-16,088 GBP2023-07-31
-26,522 GBP2022-07-31
Other Debtors
Amounts falling due within one year
13,080 GBP2023-07-31
55,778 GBP2022-07-31
Number of shares allotted
Class 1 ordinary share
100 shares2022-08-01 ~ 2023-07-31
Par Value of Share
Class 1 ordinary share
1 GBP2022-08-01 ~ 2023-07-31
Nominal value of allotted share capital
Class 1 ordinary share
100 GBP2022-08-01 ~ 2023-07-31
100 GBP2021-08-01 ~ 2022-07-31
Number of shares allotted
Class 2 ordinary share
27 shares2022-08-01 ~ 2023-07-31
Par Value of Share
Class 2 ordinary share
1 GBP2022-08-01 ~ 2023-07-31
Nominal value of allotted share capital
Class 2 ordinary share
27 GBP2022-08-01 ~ 2023-07-31
27 GBP2021-08-01 ~ 2022-07-31
Average Number of Employees
12022-08-01 ~ 2023-07-31
12021-08-01 ~ 2022-07-31

  • BRITT PHARM LTD
    Info
    FDAS BRITT LTD - 2013-04-29
    BRITT-PHARM LTD - 2013-03-08
    FDAS-BRITT LTD - 2012-08-31
    BRIT-PHARM FDAS LTD - 2012-07-26
    BRITT-PHARM LTD - 2012-05-28
    Registered number 07325977
    134a Humberston Avenue, Humberston, Grimsby DN36 4SY
    Private Limited Company incorporated on 2010-07-26 and dissolved on 2024-04-23 (13 years 8 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.